Virpax Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Virpax Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q3 2024.
  • Virpax Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 79.1 %, a 80.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 79.1 -326 -80.5% Sep 30, 2024
Q2 2024 119 -427 -78.3% Jun 30, 2024
Q1 2024 188 -509 -73.1% Mar 31, 2024
Q4 2023 270 -628 -69.9% Dec 31, 2023
Q3 2023 405 -756 -65.1% Sep 30, 2023
Q2 2023 546 -1.17K -68.2% Jun 30, 2023
Q1 2023 697 -749 -51.8% Mar 31, 2023
Q4 2022 898 -249 -21.7% Dec 31, 2022
Q3 2022 1.16K +540 +87% Sep 30, 2022
Q2 2022 1.72K Jun 30, 2022
Q1 2022 1.45K Mar 31, 2022
Q4 2021 1.15K Dec 31, 2021
Q3 2021 621 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.